ACGT

Advancing Clinico-Genomic Clinical Trials on Cancer

Abstract:
ACGT will develop a Biomedical GRID infrastructure supporting seamless mediation services for sharing clinical and Genomic expertise. Such interactions will allow joint Clinico-Genomic trials and help find quicker and efficient routes to identifying patients' individual characteristics that make one treatment more appropriate than another.

Partners:
ERCIM EEIG
Foundation for Research and Technology Hellas
Institut National de Recherche en Informatique et en Automatique
University van Amsterdam
Philips Electronics Nederland B.V.
Association Hospitaliere de Bruxelles – Centre Hospitalier Universitaire Bordet
Institut Suisse de Bioinformatique
Lunds Universitet
Universidad de Malaga
Universidad Politechnica de Madrid
Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung
A. Persidis & SIA O.E.
University of Crete
Unisersitaet Hannover
Instytut Chemii Biooganicznej pan w Poznaniu
Custodix
Healthgrid
Institute of Communications and Computer Systems
Universitaet des Saarland
S.C. SIVECO ROMANIA SA
Facultes Universitaires Notre-Dame de la Paix
Universitaet Hamburg
The Chancellor, Masters and Scholars of the University of Oxford
Hokkaido University
Istituto Europeo di Oncologia s.r.l

Duration:
February 2006 - January 2010

ERCIM's role:
Project co-ordinator

Total budget:
16 747 206 Euro

Funding Agencies:
European Commission
EC funding: 11 800 000 Euro

Links:
ACGT home page: http://acgt.ercim.org/